Biomarker-based assessment of cerebral small vessel disease progression after ischemic stroke – a prospective cohort study (MA-BIO)
Cerebral small vessel disease (CSVD) is a leading cause of ischemic stroke and vascular cognitive impairment, yet currently lacks clinically established biomarkers for monitoring disease activity. While clinical routine magnetic resonance imaging (MRI) can provide quantitative measures of structural brain changes, it d...